Accendra Health, Inc. (NYSE: ACH) Stock Competitors & Peer Comparison
See ACH's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ACH and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACH | $1.08 | +0.00% | 82.7M | 1.59 | $0.68 | N/A |
| MCK | $881.51 | +0.07% | 103.2B | 21.59 | $40.82 | +0.39% |
| COR | $321.57 | +0.19% | 62.6B | 18.75 | $17.15 | +0.75% |
| CAH | $234.57 | -0.61% | 54.9B | 22.49 | $10.43 | +0.87% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $88.36 | +1.21% | 10.1B | 16.64 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| AHG | $0.84 | +14.93% | 678.6M | -3.72 | -$0.21 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| EMPG | $17.36 | +0.00% | 143M | 192.89 | $0.09 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
ACH vs MCK Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, MCK has a market cap of 103.2B. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while MCK trades at $881.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas MCK's P/E ratio is 21.59. In terms of profitability, ACH's ROE is +0.63%, compared to MCK's ROE of -1.94%. Regarding short-term risk, ACH is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for ACH.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
ACH vs COR Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, COR has a market cap of 62.6B. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while COR trades at $321.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas COR's P/E ratio is 18.75. In terms of profitability, ACH's ROE is +0.63%, compared to COR's ROE of +1.06%. Regarding short-term risk, ACH is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for ACH.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
ACH vs CAH Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, CAH has a market cap of 54.9B. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while CAH trades at $234.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas CAH's P/E ratio is 22.49. In terms of profitability, ACH's ROE is +0.63%, compared to CAH's ROE of -0.60%. Regarding short-term risk, ACH is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for ACH.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
ACH vs ABC Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas ABC's P/E ratio is 21.92. In terms of profitability, ACH's ROE is +0.63%, compared to ABC's ROE of +1.06%. Regarding short-term risk, ACH is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for ACH.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
ACH vs HSIC Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, HSIC has a market cap of 10.1B. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while HSIC trades at $88.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas HSIC's P/E ratio is 16.64. In terms of profitability, ACH's ROE is +0.63%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, ACH is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for ACH.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
ACH vs PDCO Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas PDCO's P/E ratio is 20.48. In terms of profitability, ACH's ROE is +0.63%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, ACH is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for ACH.Check PDCO's competition here
Akso Health Group (NASDAQ: AHG)
ACH vs AHG Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, AHG has a market cap of 678.6M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while AHG trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas AHG's P/E ratio is -3.72. In terms of profitability, ACH's ROE is +0.63%, compared to AHG's ROE of -0.50%. Regarding short-term risk, ACH is less volatile compared to AHG. This indicates lower risk in terms of short-term price fluctuations for ACH.Check AHG's competition here
Owens & Minor, Inc. (NYSE: OMI)
ACH vs OMI Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas OMI's P/E ratio is -0.47. In terms of profitability, ACH's ROE is +0.63%, compared to OMI's ROE of +0.63%. Regarding short-term risk, ACH is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for ACH.Check OMI's competition here
Empro Group Inc. Ordinary shares (NASDAQ: EMPG)
ACH vs EMPG Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, EMPG has a market cap of 143M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while EMPG trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas EMPG's P/E ratio is 192.89. In terms of profitability, ACH's ROE is +0.63%, compared to EMPG's ROE of +0.66%. Regarding short-term risk, ACH is more volatile compared to EMPG. This indicates higher risk in terms of short-term price fluctuations for ACH.Check EMPG's competition here
Akso Health Group (NASDAQ: HX)
ACH vs HX Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas HX's P/E ratio is -1.84. In terms of profitability, ACH's ROE is +0.63%, compared to HX's ROE of -1.07%. Regarding short-term risk, ACH is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for ACH.Check HX's competition here
111, Inc. (NASDAQ: YI)
ACH vs YI Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, YI has a market cap of 31.1M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while YI trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas YI's P/E ratio is -2.54. In terms of profitability, ACH's ROE is +0.63%, compared to YI's ROE of +0.14%. Regarding short-term risk, ACH is less volatile compared to YI. This indicates lower risk in terms of short-term price fluctuations for ACH.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
ACH vs WGRX Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas WGRX's P/E ratio is -0.33. In terms of profitability, ACH's ROE is +0.63%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, ACH is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for ACH.Check WGRX's competition here
Zynex, Inc. (NASDAQ: ZYXI)
ACH vs ZYXI Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, ACH's ROE is +0.63%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, ACH is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for ACH.Check ZYXI's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
ACH vs MEDS Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, MEDS has a market cap of 2.4M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while MEDS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas MEDS's P/E ratio is N/A. In terms of profitability, ACH's ROE is +0.63%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, ACH is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for ACH.Check MEDS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
ACH vs HKPD Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, HKPD has a market cap of 1.3M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while HKPD trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas HKPD's P/E ratio is -2.04. In terms of profitability, ACH's ROE is +0.63%, compared to HKPD's ROE of -0.15%. Regarding short-term risk, ACH is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for ACH.Check HKPD's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
ACH vs SNYR Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, SNYR has a market cap of 1.1M. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while SNYR trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas SNYR's P/E ratio is -0.07. In terms of profitability, ACH's ROE is +0.63%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, ACH is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for ACH.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
ACH vs RDGT Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, RDGT has a market cap of 745.1K. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while RDGT trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas RDGT's P/E ratio is -0.02. In terms of profitability, ACH's ROE is +0.63%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, ACH is more volatile compared to RDGT. This indicates higher risk in terms of short-term price fluctuations for ACH.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
ACH vs CVET Comparison September 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 82.7M. In comparison, CVET has a market cap of 0. Regarding current trading prices, ACH is priced at $1.08 on the NYSE, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.59, whereas CVET's P/E ratio is -69.97. In terms of profitability, ACH's ROE is +0.63%, compared to CVET's ROE of -0.06%. Regarding short-term risk, ACH is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for ACH.Check CVET's competition here